We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Biotech Growth Trust (the) Plc | LSE:BIOG | London | Ordinary Share | GB0000385517 | ORD 25P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 22.00 | 2.27% | 993.00 | 976.00 | 994.00 | 995.00 | 984.00 | 989.00 | 41,797 | 14:23:54 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Unit Inv Tr, Closed-end Mgmt | -32.42M | -41.3M | -1.0034 | -9.92 | 409.53M |
From May 2019 to May 2024
THE BIOTECH GROWTH TRUST PLC
10 August 2020
Allotment of Ordinary Shares
THE BIOTECH GROWTH TRUST PLC (the “Company”) announces the allotment of 20,000 Ordinary shares of 25p each fully paid from its block listing authority.
These shares were issued today at a price of 1260.00 pence per Ordinary share, which equates to a premium to the estimated cum income net asset value per Ordinary share at the time of transaction of 1.4% The cum income net asset value per Ordinary share at the close of business on 7 August 2020 was 1253.26 pence.
Following this issue, the Company has the ability to issue a further 5,628,134 Ordinary shares its block listing facility.
Following this transaction the Company hereby notifies the market that it has in issue 39,637,269 Ordinary shares of 25p each all with voting rights. No shares were held in treasury at the date of announcement.
The figure of 39,637,269 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.
Enquiries:
Mark Pope
Frostrow Capital LLP
Tel: 020 3 008 4913
Copyright t 10 PR Newswire
1 Year Biotech Growth Chart |
1 Month Biotech Growth Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
